Assessing the analytical efficacy of TEX in diagnosing oral cancer using a systematic review approach.

The 5-year survival rates in OSCC depends on the stage at diagnosis. Patients have better survival and favorable outcomes if detected early, as compared to those diagnosed in advanced stages. Apart from biopsy and mucosal scraping examinations, exosomes from saliva and blood are emerging as an accessible source for diagnosis and providing additional information about the tumor's characteristics. Hence, the study of tumors-derived exosomal (TEX) biomarkers obtained from a liquid biopsy is emerging as a promising diagnostic tool.In this systematic review our effort is to assess the role of TEX as a biomarker. This article is protected by copyright. All rights reserved.